ORMP

#3821
Oramed Pharmaceuticals Inc.
3.82 USD
+0.53%
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
3.82
3.82
Rango anual
1.98
3.91
Cambio diario
+0.53%
Variación mensual
+12.02%
Variación en los últimos 6 meses
+67.54%
Cambio anual
+72.85%
Cierres anteriores
3.80
Abrir
3.82
Bid
Ask
Mínimo
3.82
High
3.82
Volumen
8
Ver el calendario completo

Financials

Visión general Informes Estadísticas Dividendos
Trimestre Año
Informe de resultados Saldo Flujo de caja
Valor Q4, 24Q1, 25Q2, 25Q3, 25Q4, 25 TTM

Oramed Pharmaceuticals Inc

Oramed Pharmaceuticals Inc., is a publicly traded company engaged in the development of oral drug delivery systems – most notably an oral insulin capsule for treating type 2 diabetes. The company was founded in 2006 and is headquartered in Jerusalem. Its shares are listed on the NASDAQ Capital Market and the Tel Aviv Stock Exchange.

Noticias